Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology  2013, Vol. 33 Issue (5): 50-55    DOI:
    
Expression, Purification and Bioactivity Identification of Recombinant Human Leukemia Inhibitory Factor (hLIF) Fusion Protein
SUN Jing, WANG Bin, DUAN Zhi-qing, HU Ning-zhu, LI Jian-fang, LI Yan-han, HU Yun-zhang
Yunnan Key Laboratory of Vaccine Research & Development on Severe Infectious Diseases, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming 650118, China
Download: HTML   PDF(615KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  Objective: To express recombinant human Leukemia inhibitory factor (hLIF) fusion protein in prokaryotic cells, purify and identify the bioactivity of expressed product. Methods: The hLIF gene was cloned into vector pThioHisA, and the constructed recombinant plasmid pThioHisA-hLIF was transformed to E.coli BL21(DE3) for expression under induction of IPTG. After the expression product waspurified by affinity chromatography, the fusion protein was tested for its specificity by western blot detection. To assess the bioactivity of the hLIF fusion protein expressed in E.coli, it was tested to maintain the pluripotency of the mouse embryonic stem cells in feeder-independent culture system. Results: Lower the induction temperature and prolong the induction time can increase soluble hLIF fusion protein expression. The recombinant protein reached a purity of more than 95% after purification, and its specificity was successfully proved by western blot detection. In feeder-independent culture system, adding hLIF fusion protein can effectively maintain the mouse embryonic stem cells in an undifferentiated state. Conclusion: The recombinant hLIF fusion protein was highly expressed in E.coli and showed good specificity, which lay the foundation for stem cells research and further research on hLIF biological functions.

Key wordsRecombinant hLIF fusion protein      Prokaryotic expression      Purification      Mouse embryonic stem cells      Bioactivity identification     
Received: 15 January 2013      Published: 25 May 2013
ZTFLH:  Q786  
Cite this article:

SUN Jing, WANG Bin, DUAN Zhi-qing, HU Ning-zhu, LI Jian-fang, LI Yan-han, HU Yun-zhang. Expression, Purification and Bioactivity Identification of Recombinant Human Leukemia Inhibitory Factor (hLIF) Fusion Protein. China Biotechnology, 2013, 33(5): 50-55.

URL:

https://manu60.magtech.com.cn/biotech/     OR     https://manu60.magtech.com.cn/biotech/Y2013/V33/I5/50

[1] 葛秀国, 徐小明, 李勇,等.白血病抑制因子与胚胎干细胞. 中国生物工程杂志, 2003, 23(12):22-30. Ge XG, Xu XM, Li Y, et al. Leukemia inhibitory factor and embryonic stem cells. China Biotechnology, 2003, 23(12):22-30.
[2] Cartwright P, McLeanC, Sheppard A, et al. LIF/STAT3 controls ES cell self-renewal and pluripotency by a Myc-dependent mechanism. Development, 2005, 132(5): 885-896.
[3] Guasch G, Fuchs E. Mice in the world of stem cell biology. Nat Genet, 2005, 37(11):1201–1206.
[4] Smith A G, Heath J K, Donaldson D D, et al. Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature, 1988,336(6200):688-90.
[5] Williams R L, Hilton D J, Pease S, et al. Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature, 1988, 336(6200):684-687.
[6] Hanna J, Cheng A W, Saha K, et al. Human embryonic stem cells with biological and epigenetic characteristics similar to those of mouse ESCs. Proc Natl Acad Sci USA, 2010, 107(20):9222–9227.
[7] Tomala M, Lavrentieva A, Moretti P, et al. Preparation of bioactive soluble human leukemia inhibitory factor from recombinant Escherichia coli using thioredoxin as fusion partner. Protein Expr Purif, 2010, 73(1):51-57.
[8] Imsoonthornruksa S, Noisa P, Parnpai R, et al. A simple method for production and purification of soluble and biologically active recombinant human leukemia inhibitory factor (hLIF) fusion protein in Escherichia coli. J Biotechnol, 2011, 151(4):295-302.
[9] 韩甫,叶荣,鲍柳君,等.小鼠胚胎干细胞无饲养层培养及其生物学特性. 苏州大学学报(医学版), 2009, 29(2):204-206. Han F,Ye R, Bao L J, et al. Culture of mouse embryonic stem cells and their biological features without feeder layer cells. Suzhou University Journal of Medical Science, 2009, 29(2):204-206.
[10] 刘登华,张苏明,闫秋月,等.无饲养层条件原代培养小鼠胚胎干细胞的实验研究. 神经损伤与功能重建, 2011, 6(3):157-160. Liu D H, Zhang S M, Yan Q Y, et al. Culture of mural embryonic stem cells under feeder-free condition. Neural Injury and Functional Reconstruction, 2011, 6(3):157-160.
[11] 赵政凯,刘畅,刘福强,等. 饲养层细胞体系及白血病抑制因子对维持小鼠胚胎干细胞未分化状态的作用. 解剖科学进展, 2009, 15(3):283-285,289. Zhao Z K, Liu C, Liu F Q, et al. Effect of feeder layer culture system and leukemia inhibitory factor on keeping mouse embryonic stem cells in undifferentiation. Progress of Anatomical Sciences, 2009, 15(3):283-285,289.
[1] QIAO Sheng-tai,WANG Man-qi,XU Hui-ni. Functional Analysis of Prokaryotic Expression Protein of Tomato SlTpx in Vitro[J]. China Biotechnology, 2021, 41(8): 25-32.
[2] ZHANG Ling,CAO Xiao-dan,YANG Hai-xu,LI Wen-lei. The Application of Continuous Purification in Affinity Chromatography and Evaluation of Production Scale-up[J]. China Biotechnology, 2021, 41(6): 38-44.
[3] ZHANG Lei,TANG Yong-kai,LI Hong-xia,LI Jian-lin,XU Yu-xin,LI Ying-bin,YU Ju-hua. Advances in Promoting Solubility of Prokaryotic Expressed Proteins[J]. China Biotechnology, 2021, 41(2/3): 138-149.
[4] ZHANG Xiao-hang,LI Yuan-yuan,JIA Min-xuan,GU Qi. Identification and Expression of Elastin-like Polypeptides[J]. China Biotechnology, 2020, 40(8): 33-40.
[5] LV Yi-fan,LI Geng-dong,XUE Nan,LV Guo-liang,SHI Shao-hui,WANG Chun-sheng. Prokaryotic Expression, Purification of LbCpf1 Protein Gene and in Vitro Cleavage Activity Assay[J]. China Biotechnology, 2020, 40(8): 41-48.
[6] JIANG Dan-dan,WANG Yun-long,LI Yu-lin,Zhang Yi-qing. Study on the Delivery of RGD Modified Virus-Like Particles to ICG Targeted Tumors[J]. China Biotechnology, 2020, 40(7): 22-29.
[7] XIE Hang-hang,BAI Hong-mei,YE Chao,CHEN Yong-jun,YUAN Ming-cui,MA Yan-bing. The Purification Procedure for the Recombinant HBcAg Virus-like Particle Easy to Generate Aggregation[J]. China Biotechnology, 2020, 40(5): 40-47.
[8] WEI Wei,CHANG Bao-gen,WANG Ying,LU Fu-ping,LIU Fu-feng. Heterologous Expression, Purification and Aggregation Characterization of Tau Core Fragment 306-378[J]. China Biotechnology, 2020, 40(5): 22-29.
[9] LI Tong-tong,SONG Cai-ling,YANG Kai-yue,WANG Wen-jing,CHEN Hui-yu,LIU Ming. Preparation and Neutralization Activity of Anti-Canine Parvovirus VP2 Protein Single-chain Antibody[J]. China Biotechnology, 2020, 40(4): 10-16.
[10] LIU Zhen-zhen,TIAN Da-yong. Development of Sucrose Density Gradient Centrifugation Purification Process for Rabies Vaccine[J]. China Biotechnology, 2020, 40(4): 25-33.
[11] CHEN Qiu-li,YANG Li-chao,LI Hui,WEN Sha,LI Gang,HE Min. Prokaryotic Expression,Purification and Preparation of Polyclonal Antibody of Human Nek2 Protein[J]. China Biotechnology, 2020, 40(3): 31-37.
[12] ZHU Tong-tong,YANG Lei,LIU Ying-bao,SUN Wen-xiu,ZHANG Xiu-guo. Purification and Crystallization of PcCRN20-C from Phytophthora capsici[J]. China Biotechnology, 2020, 40(1-2): 116-123.
[13] PAN Bing-jv,ZHANG Wan-yi,SHEN Hui-tao,LIU Ting-ting,LI Zhong-yuan,LUO Xue-gang,SONG Ya-jian. Research Progress on Separation and Purification of Mannan Oligosaccharide[J]. China Biotechnology, 2020, 40(11): 90-95.
[14] Yu-feng XIE,Xue-mei HAN,Fu-ping LU. Expression, Purification and Enzymatic Properties of β-glucosidase from Lactobacillus paracasei[J]. China Biotechnology, 2019, 39(5): 72-79.
[15] Long-bing YANG,Guo GUO,Hui-ling MA,Yan LI,Xin-yu ZHAO,Pei-pei SU,Yon ZHANG. Optimization of Prokaryotic Expression Conditions and Antifungal Activity Detection of Antibacterial Peptide AMPs17 Protein in Musca domestica[J]. China Biotechnology, 2019, 39(4): 24-31.